These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 23114160

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. C/EBPα in normal and malignant myelopoiesis.
    Friedman AD.
    Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
    [Abstract] [Full Text] [Related]

  • 4. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
    Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG.
    Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
    [Abstract] [Full Text] [Related]

  • 5. C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
    Pulikkan JA, Peramangalam PS, Dengler V, Ho PA, Preudhomme C, Meshinchi S, Christopeit M, Nibourel O, Müller-Tidow C, Bohlander SK, Tenen DG, Behre G.
    Blood; 2010 Dec 16; 116(25):5638-49. PubMed ID: 20889924
    [Abstract] [Full Text] [Related]

  • 6. K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML).
    Carnicer MJ, Lasa A, Buschbeck M, Serrano E, Carricondo M, Brunet S, Aventin A, Sierra J, Di Croce L, Nomdedeu JF.
    Ann Hematol; 2008 Oct 16; 87(10):819-27. PubMed ID: 18587575
    [Abstract] [Full Text] [Related]

  • 7. Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.
    Heyes E, Schmidt L, Manhart G, Eder T, Proietti L, Grebien F.
    Leukemia; 2021 Sep 16; 35(9):2526-2538. PubMed ID: 33623142
    [Abstract] [Full Text] [Related]

  • 8. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
    Fuchs O, Provaznikova D, Kocova M, Kostecka A, Cvekova P, Neuwirtova R, Kobylka P, Cermak J, Brezinova J, Schwarz J, Markova J, Salaj P, Klamova H, Maaloufova J, Lemez P, Novakova L, Benesova K.
    Blood Cells Mol Dis; 2008 Sep 16; 40(3):401-5. PubMed ID: 18182175
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CEBPA mutants down-regulate AML cell susceptibility to NK-mediated lysis by disruption of the expression of NKG2D ligands, which can be restored by LSD1 inhibition.
    Liu M, Du M, Yu J, Qian Z, Gao Y, Pan W, Zhao X, Wang M, Li H, Zheng J, Huang Q, Wang LM, Xiao H.
    Oncoimmunology; 2022 Sep 16; 11(1):2016158. PubMed ID: 35003895
    [Abstract] [Full Text] [Related]

  • 12. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
    Szankasi P, Ho AK, Bahler DW, Efimova O, Kelley TW.
    Leuk Res; 2011 Feb 16; 35(2):200-7. PubMed ID: 20970189
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CCAAT/enhancer binding protein-alpha polymorphisms occur more frequently than mutations in acute myeloid leukemia and exist across all cytogenetic risk groups and leukemia subtypes.
    Leecharendkeat A, Tocharoentanaphol C, Auewarakul CU.
    Int J Cancer; 2008 Nov 15; 123(10):2321-6. PubMed ID: 18729193
    [Abstract] [Full Text] [Related]

  • 19. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD.
    Mol Cancer Res; 2005 Oct 15; 3(10):585-96. PubMed ID: 16254192
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.